According to Iterum Therapeutics's latest financial reports the company's current earnings (TTM) are -$36.33 M. In 2022 the company made an earning of -$41.78 M an increase over its 2021 earnings that were of -$85.31 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$36.33 M | -13.03% |
2022 | -$41.78 M | -51.03% |
2021 | -$85.31 M | 135.87% |
2020 | -$36.17 M | -64.48% |
2019 | -$0.11 B | 33.65% |
2018 | -$76.19 M | 159.97% |
2017 | -$29.31 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$0.12 B | 204.93% | ๐บ๐ธ USA |